Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 13 Lung Neoplasms 5 Neoplasm Metastasis 4 Carcinoma, Squamous Cell 4 Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 2 Recurrence 2 Head and Neck Neoplasms 2 Glioblastoma 2 Carcinoma 2 Triple Negative Breast Neoplasms 1 Penile Neoplasms 1 Mouth Neoplasms 1 Colorectal Neoplasms 1 Brain Neoplasms 1 Advanced Malignant Solid Tumors 1 Advanced Gastric Cancer 1

Interventions

Oxaliplatin 5 Capecitabine 5 Cisplatin 4 Paclitaxel 3 Fluorouracil 3 camrelizumab 2 apatinib 2 S 1 (combination) 2 Leucovorin 2 Docetaxel 2 titanium silicide 1 rucaparib 1 relatlimab 1 pazopanib 1 linrodostat 1 ezogabine 1 endostar protein 1 dacomitinib 1 capivasertib 1 Sunitinib 1 Nivolumab 1 Metabolic Networks and Pathways 1 Irinotecan 1 Ipilimumab 1 Everolimus 1 Epirubicin 1 Electroporation 1 Drug Therapy, Combination 1 Drug Therapy 1 Congresses as Topic 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Advanced Gastric Cancer × dacomitinib × Clear all

NCT01152853 2015-11-20

PF299804-AGC

Seoul National University Hospital

Phase 2 Completed

Gastrointestinal

Advanced Gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡